BSAVA announces new president
"Becoming President is a huge honour but is part of an ongoing commitment to doing what I can to help BSAVA thrive." - Carl Gorman
Carl Gorman has been announced as the new president of the British Small Animal Veterinary Association (BSAVA), succeeding Alison Speakman. The announcement was made at the association’s annual general meeting on 15 June.
Mr Gorman has been a BSAVA member for 40 years and in 2013 he started volunteering for the southern regional committee. He is currently a clinical director of a small animal and exotics practice in Newbury which helps to train final year veterinary students in partnership with the University of Surrey.
As president, one of Mr Gorman’s main objectives will be to implement the association’s new strategy for 2024. The strategy has been developed from a current project which looks at the wider veterinary profession and how BSAVA can help its community.
Speaking about his main objectives as BSAVA president, Mr Gorman said: “Sustainability in the profession is a huge passion of mine. I established and Chair our Sustainability Working Group, made up of staff members and volunteers who look at our impact, and aim to assist the wider profession in reducing our environmental impact. During my presidential year, we will be working towards silver status with Investors in the Environment (iiE)*.
“BSAVA has always been important to me in my professional life. Since becoming a volunteer, I have admired even more the dedication of the staff and volunteers who make up the association.
“I see my time on BSAVA Board as a service to the association and to the small animal veterinary world. Becoming President is a huge honour but is part of an ongoing commitment to doing what I can to help BSAVA thrive.”
*Investors in the Environment is a national environmental accreditation scheme designed to help organisations save time, money, reduce their impact on the environment, and get recognition for their progress.
Image (C) BSAVA
BSAVA is to partner with BVA Live (11-12 June 2026) to champion clinical research.
